MRD / Regn No. : THBC\23-24\02990 Date : 17/06/2026
Patient Name : Razia Ahmed Age & Gender : 50 Yrs. / Female
Contact No. : +971507172073 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : HTN (09/Feb/2021) | DYSLIPIDEMIA (17/Jan/2024) |
Subjective : HTN- SINCE 3YRS,C/O FROZEN SHOULDER,R/O SHARJAH,DOES NOT TOLERATE ROSUVASTATIN ,TSH BORDERLINE / TG AB - NO MEDS,CAN STOP METOFRMIN ONCE STARTS OZEMPIC
Objective : MAY 26,FT3-3.62/FT4-15.98/TSH-7.17,VIT B12-1048.88,VIT D3-31.3,CR-0.78,TC-247/TG-103/HDL-54.86/LDL-172.03,HBA1C-5.5,FBS-92.11,HB-12.1,EGFR-92,JUN 26- HB-11.8,AMYLASE- 101/LIPASE- 61.1,HBA1C- 6.24/FBS- 87.80,AST- 26.2/ALT- 37.4,U ACID-6.48,TC- 179/TG- 84.9/LDL- 112/HDL- 55,TSH- 4.100
Plan : IF TAKES BEMEZY - THEN CAN STOP PIVASTA,STARTING OZEMPIC NOW - STOP METFORMIN  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TELMISARTAN 40 MG
TELMA 40 MG 		ORAL 1-0-0 ABF
 6 MTHS
2 AMLODIPIN 5MG ORAL 1-0-0 ABF
 6 MTHS
3 PIVASTA 4MG ORAL 0-0-1 ALT DAY
 6 MTHS
4 BEMEZY 180 MG ORAL 0-0-1 AD
 6 MTHS
5 INJ WEGOVY 0.25 MG SC 0.25 MG ANYTIME OF DAY
 4 WEEKS
6 INJ WEGOVY 0.5 MG SC 0.5 MG WEEKLY
 4 WEEKS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 17/Oct/2026
Tests Suggested For Next Visit : HBA1C / TSH > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: